Investors have been closely monitoring the share price objective for Mercury Laboratories Ltd., which has been a consistent performer in the pharmaceutical sector. In light of the current state of the economy and the quickening pace of change in the healthcare industry, it is critical to evaluate the company’s potential for expansion and profitability. We will examine Mercury Labs’ five-year revenue, PAT, and profit growth as we delve into the company’s outlook, finally deciding whether or not the shares are a smart investment for shareholders. Now let’s find out what the future holds for this optimistic pharmaceutical firm by taking a deeper look at the Mercury Labs share price objective for the years 2023 to 2030.
How to purchase Mercury Laboratories shares?
Below are the trading platforms that you can use to purchase Mercury Laboratories shares:
➤ Zerodha
➤ Upstox
➤ Groww
➤ AngelOne
➤ ICICIDirect
| When | Maximum Price | Minimum Price |
| October 2023 | ₹892.10 | ₹811.00 |
| November 2023 | ₹874.61 | ₹795.10 |
| December 2023 | ₹903.47 | ₹821.34 |
In 2023, Mercury Laboratories has displayed a fluctuating but generally positive trend in its share price. As of October 2023, the company’s stock reached a maximum of ₹892.10 and a minimum of ₹811.00, indicating a range of investor sentiment. Moving into November, the share price continued to exhibit resilience with a maximum of ₹874.61 and a minimum of ₹795.10, sustaining an upward trajectory.
As the year drew to a close in December, Mercury Laboratories saw its share price peak at ₹903.47, marking a high point for the year, while the minimum remained steady at ₹821.34. These fluctuations in share prices suggest that investors may have some optimism regarding the company’s performance, but also exercise caution as the market dynamics continue to evolve. The coming year will likely witness the interplay of various factors influencing Mercury Laboratories’ stock performance.
| When | Maximum Price | Minimum Price |
| January 2024 | ₹921.91 | ₹801.66 |
| February 2024 | ₹940.72 | ₹818.02 |
| March 2024 | ₹959.92 | ₹834.71 |
| April 2024 | ₹931.96 | ₹810.40 |
| May 2024 | ₹918.19 | ₹798.43 |
| June 2024 | ₹951.24 | ₹827.17 |
| July 2024 | ₹941.73 | ₹818.90 |
| August 2024 | ₹979.40 | ₹851.65 |
| September 2024 | ₹1,018.58 | ₹885.72 |
| October 2024 | ₹998.60 | ₹868.35 |
| November 2024 | ₹1,028.56 | ₹894.40 |
| December 2024 | ₹1,054.28 | ₹916.76 |
The table displays the predicted share price targets for Mercury Laboratories in 2024. The data shows a fluctuating trend in share prices throughout the year, with varying minimum and maximum price targets. In January, the stock is expected to have a maximum price of ₹921.91 and a minimum of ₹801.66. This trend continues into February and March, with the maximum price rising to ₹940.72 and ₹959.92, respectively, while the minimum prices also increase to ₹818.02 and ₹834.71.
In April and May, the share prices experience a slight dip, with a maximum of ₹931.96 in April and ₹918.19 in May, and minimum prices remaining above ₹800. The second half of the year shows a more bullish trend, with prices steadily increasing. By December, the share price is predicted to reach a maximum of ₹1,054.28, indicating potential optimism in Mercury Laboratories’ performance. Investors should closely monitor these price movements to make informed investment decisions throughout the year.
| When | Maximum Price | Minimum Price |
| January 2025 | ₹1,075.36 | ₹827.20 |
| February 2025 | ₹1,102.94 | ₹848.41 |
| March 2025 | ₹1,145.95 | ₹881.50 |
| April 2025 | ₹1,123.48 | ₹864.22 |
| May 2025 | ₹1,090.76 | ₹839.04 |
| June 2025 | ₹1,139.84 | ₹876.80 |
| July 2025 | ₹1,117.49 | ₹859.61 |
| August 2025 | ₹1,152.05 | ₹886.20 |
| September 2025 | ₹1,192.38 | ₹917.21 |
| October 2025 | ₹1,223.38 | ₹941.06 |
| November 2025 | ₹1,253.96 | ₹964.59 |
| December 2025 | ₹1,285.31 | ₹988.70 |
The table presents the anticipated share price targets for Mercury Laboratories in 2025. The data suggests a generally bullish trend in the stock prices throughout the year. In January, the maximum share price is projected to be ₹1,075.36, with a minimum of ₹827.20. This upward trend continues into February and March, with maximum prices of ₹1,102.94 and ₹1,145.95, respectively, and corresponding minimum prices. In April and May, the share prices experience a slight dip, with a minimum of ₹864.22 in April and ₹839.04 in May.
However, the prices recover in June and gradually rise further, with a maximum of ₹1,285.31 projected for December. This data suggests a generally positive outlook for Mercury Laboratories in 2025, making it potentially attractive to investors. Nonetheless, market conditions should be closely monitored for any adjustments to investment strategies.
| Year | Maximum Price | Minimum Price |
| 2026 | ₹1,349.58 | ₹944.70 |
| 2027 | ₹1,484.53 | ₹1,039.17 |
| 2028 | ₹2,078.35 | ₹1,039.17 |
| 2029 | ₹1,799.44 | ₹899.72 |
| 2030 | ₹2,339.27 | ₹1,637.49 |
According to the table, the maximum share price target for Mercury Laboratories in 2026 is ₹1,349.58, with a minimum of ₹944.70. In 2027, the maximum price is anticipated to be ₹1,484.53, and the minimum is projected to be ₹1,039.17. Notably, 2028 is expected to witness substantial growth, with the maximum price target at ₹2,078.35 and a minimum of ₹1,039.17. The positive trend continues in 2029, with the maximum price estimated at ₹1,799.44 and the minimum at ₹899.72.
In 2030, the share price is forecasted to maintain its upward trajectory, with a maximum target of ₹2,339.27 and a minimum of ₹1,637.49. These figures indicate significant growth potential for Mercury Laboratories over the next five years, making it an attractive prospect for potential investors. However, as with any investment, it’s essential for investors to conduct thorough research and consider market conditions before making decisions.
Financial Condition of Mercury Laboratories: Last 5 years
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Sales (Rs. Crores) | 55.52 | 57.27 | 68.60 | 57.92 | 75.33 |
| Expenses (Rs. Crores) | 49.79 | 51.10 | 59.01 | 50.92 | 66.76 |
| Operating Profit (Rs. Crores) | 5.73 | 6.17 | 9.59 | 7.00 | 8.57 |
| OPM % | 10.32% | 10.77% | 13.98% | 12.09% | 11.38% |
| Other Income (Rs. Crores) | 1.04 | 0.85 | 0.88 | 0.94 | 1.77 |
| Interest (Rs. Crores) | 1.09 | 0.82 | 0.64 | 0.45 | 0.36 |
| Depreciation (Rs. Crores) | 1.63 | 1.87 | 1.92 | 2.45 | 2.48 |
| Profit before Tax (Rs. Crores) | 4.05 | 4.33 | 7.91 | 5.04 | 7.50 |
| Tax % | 29.88% | 25.40% | 32.49% | 29.17% | 25.47% |
| Net Profit (Rs. Crores) | 2.84 | 3.23 | 5.34 | 3.56 | 5.58 |
| EPS (Rs.) | 23.67 | 26.92 | 44.50 | 29.67 | 46.50 |
| Dividend Payout % | 6.34% | 7.43% | 7.87% | 11.80% | 7.53% |
Mercury Laboratories has shown notable financial performance over the last five years, as reflected in its key financial metrics. The company’s sales steadily increased from ₹55.52 Crores in 2019 to ₹75.33 Crores in 2023, indicating consistent revenue growth. Operating profit also witnessed a positive trend, with operating profit margins (OPM %) remaining fairly stable within the range of 10.32% to 13.98%. Other income saw a gradual uptick, reaching ₹1.77 Crores in 2023.
Importantly, Mercury Laboratories has managed its expenses efficiently, allowing it to maintain healthy operating profits. The company’s profitability improved over this period, with net profit growing from ₹2.84 Crores in 2019 to ₹5.58 Crores in 2023. This is also evident in the rising earnings per share (EPS), which increased from ₹23.67 in 2019 to ₹46.50 in 2023. However, the dividend payout percentage exhibited some variation, increasing to 11.80% in 2022 before moderating to 7.53% in 2023. Overall, Mercury Laboratories appears to be in a robust financial position, marked by steady revenue growth and prudent financial management.
Sharekhan on Mercury Laboratories share price target
Sharekhan has given a buy call on Mercury Laboratories. According to him, you can continue buying Mercury Laboratories share with a target price of Rs680
Motilal Oswal on Mercury Laboratories share price target
Motilal Oswal has given a buy call on Mercury Laboratories. According to him, you can continue buying Mercury Laboratories share with a target price of Rs724.
FAQS
The share price target for Mercury Laboratories for 2023-2030 ranges from INR 1,093.08 to INR 4,548.05.
Can Mercury Laboratories reach INR 5000 by 2025?
Based on the available data, it is not predicted that Mercury Laboratories will reach INR 5000 by 2025.
Several factors may influence the share price of Mercury Laboratories, including the company’s financial performance, competition in the pharmaceutical industry, changes in regulations, and global economic trends.
What is the growth rate predicted for Mercury Laboratories?
The growth rate predicted for Mercury Laboratories varies across different years, but the average growth rate is estimated to be around 15-20%.
What is the company’s financial performance in recent years?
Mercury Laboratories has reported strong financial performance in recent years, with an increase in revenue and profits.
What is the analyst recommendation for investing in Mercury Laboratories?
The analyst recommendation for investing in Mercury Laboratories may vary across different analysts and investment firms. It is recommended to consult with a financial advisor before making any investment decisions.
How can one invest in Mercury Laboratories?
Investing in Mercury Laboratories can be done through the Indian stock market by purchasing the company’s shares through a stockbroker or an online trading platform. It is important to conduct thorough research and analysis before making any investment decisions.
ALSO READ:
- NEOGEN CHEMICALS LTD SHARE PRICE TARGET 2023, 2024, 2025 to 2030
- CEAT Share Price Target 2023 to 2030: Can CEAT LTD touch 2500 INR in 2023?
- APOLLO PIPES SHARE PRICE TARGET 2023, 2024, 2025 to 2030
Conclusion
Mercury Laboratories has demonstrated constant development over the course of the last five years, as seen by the growth in income, PAT, revenue, and profit. At a growth rate of 32.21%, the company’s sales climbed from 51.86 crore in 2018 to 68.6 crore in 2021. At a growth rate of 165.17%, the PAT increased from 2.01 crore in 2018 to 5.34 crore in 2021. Additionally, over the previous five years, the profit growth rate was 83.29%. With a P/E ratio of 15.77 as of March 2022, Mercury Laboratories’ share price has held steady despite the stock market’s turbulence. Investors may find the company to be a solid investment choice given its expansion and steady share price.
What did we learn?
- 1 Mercury Laboratories Share Price Target: 2023 to 2030
- 2 Financial Condition of Mercury Laboratories: Last 5 years
- 3 Mercury Laboratories share price target by Experts
- 4 FAQS
- 4.1 What is the share price target for Mercury Laboratories for 2023-2030?
- 4.2 Can Mercury Laboratories reach INR 5000 by 2025?
- 4.3 What factors influence the share price of Mercury Laboratories?
- 4.4 What is the growth rate predicted for Mercury Laboratories?
- 4.5 What is the company’s financial performance in recent years?
- 4.6 What is the analyst recommendation for investing in Mercury Laboratories?
- 4.7 How can one invest in Mercury Laboratories?
- 5 Conclusion
Twitter
Linkedin
